- Home
- ELVN vs ALX Comparison
ELVN vs ALX Comparison
Compare ELVN & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | ALX |
|---|---|---|
| Founded | 2016 | 1928 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | ALX |
|---|---|---|
| Price | $16.34 | $216.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $41.00 | N/A |
| AVG Volume (30 Days) | ★ 808.8K | 58.1K |
| Earning Date | 11-12-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.14 |
| Revenue | N/A | ★ $215,838,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $30.56 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.30 | $184.76 |
| 52 Week High | $25.37 | $260.84 |
Technical Indicators
Market Signals| Indicator | ELVN | ALX |
|---|---|---|
| Relative Strength Index (RSI) | 37.75 | 50.61 |
| Support Level | $15.71 | $213.00 |
| Resistance Level | $18.05 | $219.64 |
| Average True Range (ATR) | 1.39 | 4.26 |
| MACD | -0.19 | 0.61 |
| Stochastic Oscillator | 10.61 | 60.92 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.